Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Foresee Pharmaceuticals Co., Ltd. (6576) Financial Statements

Foresee Pharmaceuticals Co., Ltd. Financial Overview

Foresee Pharmaceuticals Co., Ltd.'s market cap is currently NT$11.52B. The company's EPS TTM is NT$0.14; its P/E ratio is 519.28; Foresee Pharmaceuticals Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 431.27MNT$ 418.69MNT$ 195.04MNT$ 301.51MNT$ 226.03M
Gross ProfitNT$ 294.22MNT$ 239.80MNT$ 113.97MNT$ 275.97MNT$ 175.08M
Operating IncomeNT$ -862.32MNT$ -1.08BNT$ -1.01BNT$ -437.73MNT$ -527.31M
EBITDANT$ -784.50MNT$ -945.98MNT$ -912.16MNT$ -386.58MNT$ -475.83M
Net IncomeNT$ -883.15MNT$ -1.08BNT$ -1.04BNT$ -472.64MNT$ -569.27M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 700.22MNT$ 1.44BNT$ 1.35BNT$ 689.50MNT$ 1.27B
Total AssetsNT$ 1.31BNT$ 2.16BNT$ 1.86BNT$ 1.30BNT$ 1.64B
Total DebtNT$ 231.74MNT$ 260.32MNT$ 228.26MNT$ 41.32MNT$ 16.65M
Net DebtNT$ -247.78MNT$ -1.11BNT$ -781.42MNT$ -648.19MNT$ -854.79M
Total LiabilitiesNT$ 380.78MNT$ 560.15MNT$ 616.93MNT$ 393.43MNT$ 321.26M
Stockholders' EquityNT$ 929.61MNT$ 1.60BNT$ 1.24BNT$ 910.58MNT$ 1.32B
Cash Flow
Free Cash FlowNT$ -857.73MNT$ -1.33BNT$ -933.84MNT$ -291.29MNT$ -220.98M
Operating Cash FlowNT$ -842.23MNT$ -1.17BNT$ -887.55MNT$ -233.22MNT$ -213.33M
Investing Cash FlowNT$ -161.75MNT$ 112.82MNT$ -296.08MNT$ 40.70MNT$ 17.62M
Financing Cash FlowNT$ 134.18MNT$ 1.41BNT$ 1.50BNT$ 2.86MNT$ -75.74M

Currency in TWD

Foresee Pharmaceuticals Co., Ltd. Earnings and Revenue History

-1.2B-600M0600M-750 %-500 %-250 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Foresee Pharmaceuticals Co., Ltd. Liabilities to Assets

0800M1.6B2.4B10 %20 %30 %40 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Foresee Pharmaceuticals Co., Ltd. Cash Flow

-1.5B-1B-500M0500M1B1.5B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Foresee Pharmaceuticals Co., Ltd. Forecast EPS vs Actual EPS

-3-2-101234Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >